Results 81 to 90 of about 309,486 (306)

Flexible wearable electronics for cardiovascular monitoring from surface signals to deep physiological insights

open access: yesFlexMat, EarlyView.
This review organizes flexible wearable electronics for cardiovascular monitoring into four interconnected information layers: surface electrophysiology, hemodynamic sensing, vascular imaging, and biofluid biomarker analysis. This framework clarifies how electrical rhythm, vascular loading, structural and flow‐related features, and biochemical states ...
Qiao Chen   +5 more
wiley   +1 more source

Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: a population-based nested case-referent study

open access: yesOpen Heart, 2020
Aims High-sensitivity troponin T (hs-TnT) and high-sensitivity C reactive protein (hs-CRP) may convey prognostic information in patients with aortic stenosis (AS).
Bengt Johansson   +6 more
doaj   +1 more source

Concordant and discordant roles of remnant cholesterol and hs-CRP in cardiovascular disease; gender stratified analysis. [PDF]

open access: yesLipids Health Dis
Introduction Evidence has found that high-sensitivity C-reactive protein (hs-CRP) can predict cardiovascular disease (CVD). Additionally, some research has suggested a combined effect of hs-CRP and remnant cholesterol (RC) in the development of CVD ...
Kamrani F   +12 more
europepmc   +2 more sources

Baseline participant characteristics by hs-CRP category.

open access: yes, 2017
Baseline participant characteristics by hs-CRP category.
Seungho Ryu (164515)   +4 more
core   +1 more source

Correlation of high-sensitivity C-reactive protein with blood sugar level in patients with Type 2 diabetes

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2018
Background: The prevalence of diabetes is rapidly rising all over the globe at an alarming rate. Complications of diabetes include microvascular and macrovascular complications.
Leya Elizabeth Babu, Anuradha Joshi
doaj   +1 more source

Redefining Fatty Liver Disease: How Updated Nomenclature Reshapes Clinical Laboratory Diagnostics

open access: yesiLABMED, EarlyView.
The transition from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction‐associated steatotic liver disease (MASLD) reorients laboratory diagnosis from exclusion‐based rules toward metabolic and inflammatory biomarkers. This review compares their diagnostic criteria, epidemiology, insulin resistance mechanisms, imaging, and key laboratory ...
Ran Wei   +3 more
wiley   +1 more source

Prognostic significance of hs-CRP in acute ischemic stroke patients

open access: yes, 2018
Background: Stroke, a serious neurological disease is a major cause of death and disability throughout world. The pathophysiology of stroke involves inflammatory pathways, oxidative damage, apoptosis, angiogenesis and neuroprotection. High sensitivity C -
P. Dwivedi, K. K. Kawre, Sonika Pandey
core   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Tofacitinib Regulates β‐Catenin Nuclear Translocation to Inhibit FLS Migration and Alleviate Clinical Symptoms of RA

open access: yesiNew Medicine, EarlyView.
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang   +13 more
wiley   +1 more source

ATP Citrate Lyase in Metabolic Disease: Mechanistic Insights and Clinical Potential

open access: yesiNew Medicine, EarlyView.
ATP citrate lyase (ACLY) is a central metabolic hub that diverts mitochondrial citrate to fuel de novo lipogenesis, cholesterol biosynthesis, and protein acetylation. Given its robust correlation with pathological changes in multiple human diseases, ACLY inhibitors featuring distinct pharmacological strengths have been developed for therapeutic ...
Wenbiao Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy